Stock ICAD ICAD, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News iCAD, Inc.

Equities

ICAD

US44934S2068

Real-time Estimate Cboe BZX
Other stock markets
 12:17:36 2024-04-26 pm EDT 		5-day change 1st Jan Change
1.45 USD -2.03% Intraday chart for iCAD, Inc. -7.14% -19.21%
Apr. 11 ICAD, Inc. Showcases New Profound Cloud, Enhanced Profound Detection Workstation Features at SBI Annual Symposium CI
Apr. 09 ICAD, Inc. and Densitas, Inc. Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
ICAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual Symposium
AQ
ICAD, Inc. Showcases New Profound Cloud, Enhanced Profound Detection Workstation Features at SBI Annual Symposium
CI
ICAD and Densitas Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation
AQ
ICAD, Inc. and Densitas, Inc. Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation
CI
ICAD’s ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting
AQ
ICAD Partners with RAD-AID to Advance Breast Cancer Detection Using AI in Underserved Regions and Low- and Middle-Income Countries (LMICs)
AQ
ICAD Unveils ProFound Cloud, Enabling Interoperability and Access to Breast AI Solutions at Enterprise Scale
AQ
ICAD, Inc. Announces Commercial Availability of ProFound Cloud
CI
ICAD Releases Enhanced ProFound Detection Workstation Features to Streamline Mammogram Interpretation for Radiologists
AQ
Transcript : ICAD, Inc., Q4 2023 Earnings Call, Mar 12, 2024
Earnings Flash (ICAD) ICAD Posts Q4 Revenue $4.7M, vs. Street Est of $4.3M
MT
ICAD, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
ICAD Announces Fiscal Fourth Quarter and Full-Year 2023 Financial Results
AQ
ICad to Present Three Mammography Studies at Radiology Conference; Shares Rise
MT
ICAD Highlights Promising Clinical Data Demonstrating Ability to Reduce Breast Interval Cancer Rates and Decrease Recall Rates at ECR 2024; Showcases Additional Platform Offerings
AQ
ICAD expands Board of Directors with the appointment of Dr. Hedvig Hricak, MD, PhD, (Dr.h.cᵐ)
AQ
ICAD to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
AQ
ICAD, Inc. Appoints Hedvig Hricak to the Board of Directors
CI
ICAD to Participate in the BTIG at Snowbird: 11th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
AQ
ICAD Expands Board of Directors with Appointment of Michael J. Doyle, FACHE as New Board Member
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ICAD Stock
  4. News iCAD, Inc.